المؤلفون: Colclough, N, Chen, K, Johnstrom, P, Strittmatter, N, Yan, YM, Wrigley, GL, Schou, M, Goodwin, R, Varnas, K, Adua, SJ, Zhao, M, Nguyen, DX, Maglennon, G, Barton, P, Atkinson, J, Zhang, L, Janefeldt, A, Wilson, J, Smith, A, Takano, A, Arakawa, R, Kondrashov, M, Malmquist, J, Revunov, E, Vazquez-Romero, A, Moein, MM, Windhorst, AD, Karp, NA, Finlay, MRV, Ward, RA, Yates, JWT, Smith, PD, Farde, L, Cheng, Z, Cross, DAE

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 27(1):189-201

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:145678222

المؤلفون: Colclough, N, Ballard, PG, Barton, P, Chen, K, Cross, DAE, Finlay, MRV, Han, L, Janefeldt, A, Johnstrom, P, Ward, RA, Wrigley, GL, Yana, Y, Yates, JWT, Zhang, D, Zhang, Z

المصدر: EUROPEAN JOURNAL OF CANCER. 69:S28-S28

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:134819398

المؤلفون: Mfuh AM; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Boerth JA; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Bommakanti G; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Chan C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Chinn AJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Code E; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Fricke PJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Giblin KA; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Gohlke A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hansel C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hariparsad N; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Hughes SJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Jin M; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Kantae V; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Kavanagh SL; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Lamb ML; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Lane J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Moore R; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Puri T; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Quinn TR; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Reddy I; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Robb GR; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Robbins KJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Gancedo Rodrigo M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Isomorphic Laboratories, 280 Bishopsgate, London EC2M 4RB, U.K., Schimpl M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Singh B; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Singh M; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Tang H; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Thomson C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Walsh JJ; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Ware J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Watson IDG; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Ye MW; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Wrigley GL; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Zhang AX; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Zhang Y; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Grimster NP; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

المصدر: Journal of medicinal chemistry [J Med Chem] 2024 Jan 25; Vol. 67 (2), pp. 1500-1512. Date of Electronic Publication: 2024 Jan 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins c-cbl*/metabolism , Ubiquitin-Protein Ligases*/metabolism, T-Lymphocytes/metabolism ; Phosphorylation ; Ubiquitin/metabolism

المؤلفون: Boerth JA; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Chinn AJ; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Schimpl M; Discovery Sciences, R&D, The Discovery Centre, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Bommakanti G; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Chan C; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Code EL; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Giblin KA; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Gohlke A; Discovery Sciences, R&D, The Discovery Centre, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Hansel CS; Discovery Sciences, R&D, The Discovery Centre, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Jin M; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Kavanagh SL; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Lamb ML; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Lane JS; Discovery Sciences, R&D, The Discovery Centre, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Larner CJB; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Mfuh AM; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Moore RK; High Throughput Screening, Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, United Kingdom., Puri T; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Quinn TR; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Ye M; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Robbins KJ; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Gancedo-Rodrigo M; Discovery Sciences, R&D, The Discovery Centre, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Tang H; Discovery Sciences, R&D, The Discovery Centre, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Walsh J; High Throughput Screening, Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, United Kingdom., Ware J; Discovery Sciences, R&D, The Discovery Centre, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Wrigley GL; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Reddy IK; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Zhang Y; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Grimster NP; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

المصدر: ACS medicinal chemistry letters [ACS Med Chem Lett] 2023 Nov 17; Vol. 14 (12), pp. 1848-1856. Date of Electronic Publication: 2023 Nov 17 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE

المؤلفون: Cao Q; Department of Chemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK., Tibbetts JD; Department of Chemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK., Wrigley GL; Medicinal Chemistry, Oncology R&D, AstraZeneca, Cambridge, CB4 0WG, UK., Smalley AP; UCB, 216 Bath Road, Slough, SL1 3WE, UK., Cresswell AJ; Department of Chemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK. a.j.cresswell@bath.ac.uk.

المصدر: Communications chemistry [Commun Chem] 2023 Oct 04; Vol. 6 (1), pp. 215. Date of Electronic Publication: 2023 Oct 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 101725670 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3669 (Electronic) Linking ISSN: 23993669 NLM ISO Abbreviation: Commun Chem Subsets: PubMed not MEDLINE

المؤلفون: Finlay MRV, Anderton M, Bailey A, Boyd S, Brookfield J, Cairnduff C, Charles M, Cheasty A, Critchlow SE, Culshaw J, Debreczeni J, Ekwuru T, Hollingsworth I, Jones N, Leroux F, Littleson M, McCarron H, McKelvie J, Mooney L, Nissink JWM, Patel J, Perkins D, Powell S, Quesada MJ, Raubo P, Sabin V, Smith J, Smith PD, Stark A, Ting A, Wang P, Wilson Z, Winter-Holt JJ, Wood JM, Wrigley GL, Yu G, Zhang P

المصدر: Journal of medicinal chemistry [J Med Chem] 2023 Jul 13; Vol. 66 (13), pp. 9223-9224. Date of Electronic Publication: 2023 Jun 21.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Jones SP; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk., Firth JD; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk., Wheldon MC; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk., Atobe M; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.; Asahi Kasei Pharma Corporation 632-1 Mifuku, Izunokuni Shizuoka 410-2321 Japan., Hubbard RE; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.; Vernalis (R&D) Ltd. Granta Park, Abington Cambridge CB21 6GB UK., Blakemore DC; Medicine Design, Pfizer Inc. 445 Eastern Point Road Groton CT 06340 USA., De Fusco C; Bayer AG, Research and Development, Pharmaceuticals, Synthetic Modalities 13353 Berlin Germany., Lucas SCC; Hit Discovery, Discovery Sciences, R&D, AstraZeneca Cambridge CB4 0WG UK., Roughley SD; Vernalis (R&D) Ltd. Granta Park, Abington Cambridge CB21 6GB UK., Vidler LR; Amphista Therapeutics The Cori Building, Granta Park, Great Abington Cambridge CB21 6GQ UK., Whatton MA; Evotec (UK) Ltd Dorothy Crowfoot Hodgkin Campus, 114 Innovation Drive, Milton Park, Abingdon Oxon OX14 4RZ UK., Woolford AJ; Astex Pharmaceuticals 436 Cambridge Science Park, Milton Road Cambridge CB4 0QA UK., Wrigley GL; Medicinal Chemistry, Oncology R&D, AstraZeneca Cambridge UK., O'Brien P; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.

المصدر: RSC medicinal chemistry [RSC Med Chem] 2022 Oct 11; Vol. 13 (12), pp. 1614-1620. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101759460 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8682 (Electronic) Linking ISSN: 26328682 NLM ISO Abbreviation: RSC Med Chem Subsets: PubMed not MEDLINE

المؤلفون: Askey HE; Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K., Grayson JD; Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K., Tibbetts JD; Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K., Turner-Dore JC; Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K., Holmes JM; Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K., Kociok-Kohn G; Materials and Chemical Characterisation Facility (MC2), University of Bath, Claverton Down, Bath BA2 7AY, U.K., Wrigley GL; Oncology R&D, Research & Early Development, AstraZeneca, Darwin Building, 310, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Cresswell AJ; Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K.

المصدر: Journal of the American Chemical Society [J Am Chem Soc] 2021 Oct 06; Vol. 143 (39), pp. 15936-15945. Date of Electronic Publication: 2021 Sep 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 7503056 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5126 (Electronic) Linking ISSN: 00027863 NLM ISO Abbreviation: J Am Chem Soc Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Degorce SL; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States. Electronic address: sebastien.degorce@astrazeneca.com., Aagaard A; Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-431 83 Mölndal, Sweden., Anjum R; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Cumming IA; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Diène CR; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Fallan C; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Johnson T; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Leuchowius KJ; Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-431 83 Mölndal, Sweden., Orton AL; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Pearson S; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Robb GR; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Rosen A; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Scarfe GB; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Scott JS; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Smith JM; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Steward OR; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Terstiege I; Medicinal Chemistry, R&I, R&D, AstraZeneca, Gothenburg, SE-431 83 Mölndal, Sweden., Tucker MJ; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Turner P; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Wilkinson SD; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Wrigley GL; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Xue Y; Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-431 83 Mölndal, Sweden.

المصدر: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2020 Dec 01; Vol. 28 (23), pp. 115815. Date of Electronic Publication: 2020 Oct 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3391 (Electronic) Linking ISSN: 09680896 NLM ISO Abbreviation: Bioorg Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-1 Receptor-Associated Kinases/*antagonists & inhibitors , Protein Kinase Inhibitors/*metabolism , Quinazolines/*chemistry, Aldehyde Oxidase/metabolism ; Animals ; Binding Sites ; Cell Line, Tumor ; Cell Survival/drug effects ; Crystallography, X-Ray ; Dogs ; Drug Stability ; Half-Life ; Hepatocytes/metabolism ; Humans ; Interleukin-1 Receptor-Associated Kinases/metabolism ; Mice ; Microsomes, Liver/metabolism ; Molecular Dynamics Simulation ; Protein Kinase Inhibitors/chemistry ; Protein Kinase Inhibitors/pharmacology ; Quinazolines/metabolism ; Quinazolines/pharmacology ; Rats ; Structure-Activity Relationship

المؤلفون: Downes TD; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Jones SP; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Klein HF; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Wheldon MC; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Atobe M; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.; Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni, Shizuoka, 410-2321, Japan., Bond PS; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Firth JD; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Chan NS; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Waddelove L; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Hubbard RE; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.; Vernalis (R&D) Ltd, Granta Park, Abington, Cambridge, CB21 6GB, UK., Blakemore DC; Medicine Design, Pfizer Inc, 445 Eastern Point Road, Groton, CT 06340, USA., De Fusco C; Discovery Sciences, R&D, AstraZeneca, Cambridge, CB4 0WG, UK., Roughley SD; Vernalis (R&D) Ltd, Granta Park, Abington, Cambridge, CB21 6GB, UK., Vidler LR; Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK., Whatton MA; Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK., Woolford AJ; Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA, UK., Wrigley GL; Medicinal Chemistry, Oncology R&D, AstraZeneca, CB4 0WG, Cambridge, UK., O'Brien P; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.

المصدر: Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2020 Jul 22; Vol. 26 (41), pp. 8969-8975. Date of Electronic Publication: 2020 Jul 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 9513783 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3765 (Electronic) Linking ISSN: 09476539 NLM ISO Abbreviation: Chemistry Subsets: PubMed not MEDLINE; MEDLINE